Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.

Xue D, He X, Zhou C.

Transplant Proc. 2014 Jan-Feb;46(1):156-9. doi: 10.1016/j.transproceed.2013.06.020.

PMID:
24507043
2.
3.

Hemojuvelin and iron metabolism in kidney and heart allograft recipients.

Przybylowski P, Koc-Zorawska E, Glowinska I, Levin-Iaina N, Macdougall IC, Malyszko JS, Mysliwiec M, Malyszko J.

Transplant Proc. 2013 Jan-Feb;45(1):391-3. doi: 10.1016/j.transproceed.2012.02.041.

PMID:
23375327
4.

Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.

Rubab Z, Amin H, Abbas K, Hussain S, Ullah MI, Mohsin S.

Saudi J Kidney Dis Transpl. 2015 Jan;26(1):19-25.

5.

Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.

Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M.

Transplant Proc. 2006 Nov;38(9):2895-8.

PMID:
17112858
6.

Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease.

Samouilidou E, Pantelias K, Petras D, Tsirpanlis G, Bakirtzi J, Chatzivasileiou G, Tzanatos H, Grapsa E.

Ther Apher Dial. 2014 Jun;18(3):279-83. doi: 10.1111/1744-9987.12102. Epub 2013 Sep 30.

PMID:
24119290
7.

Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients.

Sany D, Elsawy AE, Elshahawy Y.

Saudi J Kidney Dis Transpl. 2014 Sep;25(5):967-73.

8.

A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.

Malyszko J, Malyszko JS, Mysliwiec M.

Transplant Proc. 2009 Oct;41(8):3056-9. doi: 10.1016/j.transproceed.2009.08.003.

PMID:
19857675
9.

Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.

Hong JH, Choi YK, Min BK, Park KS, Seong K, Lee IK, Kim JG.

Diabetes Res Clin Pract. 2015 Jul;109(1):64-70. doi: 10.1016/j.diabres.2015.05.001. Epub 2015 May 11.

PMID:
25998917
10.

Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.

Bergamaschi G, Di Sabatino A, Albertini R, Costanzo F, Guerci M, Masotti M, Pasini A, Massari A, Campostrini N, Corbella M, Girelli D, Corazza GR.

Inflamm Bowel Dis. 2013 Sep;19(10):2166-72. doi: 10.1097/MIB.0b013e31829a6e43.

PMID:
23867871
11.

Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin.

Eleftheriadis T, Pissas G, Remoundou M, Filippidis G, Antoniadi G, Oustampasidou N, Liakopoulos V, Stefanidis I.

Int Urol Nephrol. 2014 Jan;46(1):161-7. doi: 10.1007/s11255-013-0497-9. Epub 2013 Jul 17.

PMID:
23860963
12.

Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.

Przybyłowski P, Wasilewski G, Bachorzewska-Gajewska H, Golabek K, Dobrzycki S, Małyszko J.

Transplant Proc. 2014 Oct;46(8):2852-5. doi: 10.1016/j.transproceed.2014.09.040.

PMID:
25380934
13.

Hepcidin, iron status, and inflammation variables among healthy pregnant women in the Turkish population.

Simavli S, Derbent AU, Uysal S, Turhan NÖ.

J Matern Fetal Neonatal Med. 2014 Jan;27(1):75-9. doi: 10.3109/14767058.2013.804054. Epub 2013 Jun 14.

PMID:
23662610
14.

Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.

Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M.

Am J Hematol. 2006 Nov;81(11):832-7.

15.

Effects of a 7-day military training exercise on inflammatory biomarkers, serum hepcidin, and iron status.

McClung JP, Martini S, Murphy NE, Montain SJ, Margolis LM, Thrane I, Spitz MG, Blatny JM, Young AJ, Gundersen Y, Pasiakos SM.

Nutr J. 2013 Nov 4;12(1):141. doi: 10.1186/1475-2891-12-141.

16.

Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.

Arnold J, Sangwaiya A, Bhatkal B, Geoghegan F, Busbridge M.

Eur J Gastroenterol Hepatol. 2009 Apr;21(4):425-9. doi: 10.1097/MEG.0b013e32830e2885.

PMID:
19262400
17.

Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.

Zipperer E, Post JG, Herkert M, Kündgen A, Fox F, Haas R, Gattermann N, Germing U.

Ann Hematol. 2013 Dec;92(12):1617-23. doi: 10.1007/s00277-013-1839-5. Epub 2013 Jul 11.

PMID:
23842708
18.

Relationship between hepcidin and ferritin in haemodialysed patients.

Sedlackova T, Racek J, Rajdl D, Kielberger L, Eiselt J, Malanova L, Babuska V.

Wien Klin Wochenschr. 2013 Aug;125(15-16):448-52. doi: 10.1007/s00508-013-0388-1. Epub 2013 Jun 27.

PMID:
23807042
19.

Comparison of serum levels of hepcidin and pro-hepcidin in hemodialysis patients and healthy subjects.

Taheri N; Gh Roshandel, Mojerloo M, Hadad M, Mirkarimi H, Nejad RK, Joshaghani HR.

Saudi J Kidney Dis Transpl. 2015 Jan;26(1):34-8.

20.

A possible role of hepcidin in the pathogenesis of anemia in heart allograft recipients.

Przybylowski P, Malyszko J, Malyszko JS.

Transplant Proc. 2010 Jun;42(5):1803-7. doi: 10.1016/j.transproceed.2010.03.139.

PMID:
20620527

Supplemental Content

Support Center